Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma is a research paper published in Oncoscience (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 4UL1TR000371-10
Center for Clinical and Translational Sciences (CCTS)
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 1R01CA273168-01
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
National Institutes of Health
Grant: 5U01CA180964-02
Informatics to enable routine personalized cancer therapy
National Institutes of Health
Grant: 5R01CA242845-04
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
FWCI
0.33
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals